ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
119.567,53
-0,31%
S&P 500
5.433,74
0,23%
US Dollar vs BRL
5,3634
0,01%
Bitcoin
67.153,11
0,59%
Brent Oil
82,025
0,06%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Lantheus Holdings Inc (LNTH)

  7. Lantheus Holdings Inc (LNTH) Notícias

LNTH

Lantheus (LNTH)

Lantheus Holdings Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:LNTH
DataHoraFonteTítuloCódigoCompanhia
13/06/202411:17Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:LNTHLantheus Holdings Inc
06/06/202418:50Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:LNTHLantheus Holdings Inc
04/06/202417:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LNTHLantheus Holdings Inc
03/06/202409:30GlobeNewswire Inc.Lantheus’ AI-Enabled aPROMISE Now Available on Siemens Healthineers’ syngo.via platformNASDAQ:LNTHLantheus Holdings Inc
31/05/202417:30Edgar (US Regulatory)Form SD - Specialized disclosure reportNASDAQ:LNTHLantheus Holdings Inc
28/05/202409:00GlobeNewswire Inc.Lantheus to Present at the William Blair 44th Annual Growth Stock ConferenceNASDAQ:LNTHLantheus Holdings Inc
15/05/202417:43Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LNTHLantheus Holdings Inc
15/05/202417:30GlobeNewswire Inc.Lantheus Announces Executive Appointments to Accelerate InnovationNASDAQ:LNTHLantheus Holdings Inc
02/05/202408:00GlobeNewswire Inc.Lantheus Reports First Quarter 2024 Financial ResultsNASDAQ:LNTHLantheus Holdings Inc
18/04/202409:00GlobeNewswire Inc.Lantheus to Host First Quarter 2024 Earnings Conference Call and Webcast on May 2, 2024, at 8:00 a.m. Eastern TimeNASDAQ:LNTHLantheus Holdings Inc
05/03/202410:30GlobeNewswire Inc.Lantheus to Present at the Leerink Partners Global Biopharma Conference 2024NASDAQ:LNTHLantheus Holdings Inc
04/03/202410:30GlobeNewswire Inc.Lantheus Announces the FDA Approval of DEFINITY® (Perflutren Lipid Microsphere) for Pediatric PatientsNASDAQ:LNTHLantheus Holdings Inc
28/02/202410:30GlobeNewswire Inc.Lantheus Announces Promotion of Amanda Morgan to Chief Commercial OfficerNASDAQ:LNTHLantheus Holdings Inc
26/02/202410:30GlobeNewswire Inc.Lantheus to Present at the TD Cowen 44th Annual Health Care ConferenceNASDAQ:LNTHLantheus Holdings Inc
22/02/202409:49Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:LNTHLantheus Holdings Inc
22/02/202409:00GlobeNewswire Inc.Lantheus Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:LNTHLantheus Holdings Inc
13/02/202410:30GlobeNewswire Inc.Lantheus Announces Collaboration to Provide Novel Tau Imaging Agent for Large Consortium Clinical Trial Sponsored by the National Institute on AgingNASDAQ:LNTHLantheus Holdings Inc
08/02/202410:00GlobeNewswire Inc.Lantheus to Host Fourth Quarter and Full Year 2023 Earnings Conference Call and Webcast on February 22, 2024, at 8:00 a.m. Eastern TimeNASDAQ:LNTHLantheus Holdings Inc
23/01/202409:45GlobeNewswire Inc.Lantheus Announces CEO Succession PlanNASDAQ:LNTHLantheus Holdings Inc
11/01/202410:00GlobeNewswire Inc.Lantheus Announces Acceptance of its First-to-File ANDA for Generic LUTATHERA® (Lutetium Lu 177 Dotatate)NASDAQ:LNTHLantheus Holdings Inc
09/01/202410:00GlobeNewswire Inc.Lantheus Expands Radiopharmaceutical Oncology Pipeline via Strategic Agreements with Perspective TherapeuticsNASDAQ:LNTHLantheus Holdings Inc
09/01/202409:55GlobeNewswire Inc.Lantheus Reports Preliminary Fiscal Year 2023 RevenueNASDAQ:LNTHLantheus Holdings Inc
03/01/202410:30GlobeNewswire Inc.Lantheus to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:LNTHLantheus Holdings Inc
18/12/202309:30GlobeNewswire Inc.Lantheus and POINT Biopharma Announce Positive Topline Results from Pivotal SPLASH Trial in Metastatic Castration-Resistant Prostate CancerNASDAQ:LNTHLantheus Holdings Inc
08/11/202310:00GlobeNewswire Inc.Lantheus to Present at the Jefferies London Healthcare ConferenceNASDAQ:LNTHLantheus Holdings Inc
02/11/202308:51Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LNTHLantheus Holdings Inc
02/11/202308:00GlobeNewswire Inc.Lantheus Reports Third Quarter 2023 Financial ResultsNASDAQ:LNTHLantheus Holdings Inc
19/10/202309:00GlobeNewswire Inc.Lantheus to Host Third Quarter 2023 Earnings Conference Call and Webcast on November 2, 2023, at 8:00 a.m. Eastern TimeNASDAQ:LNTHLantheus Holdings Inc
01/09/202309:30GlobeNewswire Inc.Lantheus Announces Top Rated Oral Presentation Featuring PYLARIFY AI™ at the 2023 European Association of Nuclear Medicine (EANM) Annual MeetingNASDAQ:LNTHLantheus Holdings Inc
31/08/202309:00GlobeNewswire Inc.Lantheus to Present at the Wells Fargo Healthcare ConferenceNASDAQ:LNTHLantheus Holdings Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:LNTH

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
OIBR3
OI ON
BOV
RRRP3
3R Petroleum Oleo E Gas ... ON
BOV
AMER3
Americanas ON
BOV
COGN3
COGNA ON
BOV
SEQL3
Sequoia Logistica e Tran... ON
BOV
MGLU3
MAGAZINE LUIZA ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados